Drug discovery validated disease target

Drug target discovery, which involves the identification and early validation of disease-associated targets, is the-first step in the drug discovery pipeline. Disease involves alterations in gene and/or protein expression and... 

Drug-discovery process is a highly complex, multidisciplinary and time-consuming procedure, which typically starts from the identification of appropriate drug targets (biomolecules, enzymes, ion channels, receptors) to target validation, where it was established whether the target was of relevance for the disease under study. 

A number of valid reasons have prompted the research-oriented chemical industry to invest substantial resources into the effort to dramatically increase the evaluation efficiency of new chemical entities. The objective is to optimize rapidity and cost in the early phases of the process, leading to the identification of compounds with promising properties for further development into commercial products (typically pharmaceuticals or agrochemicals). In drug discovery, the wealth of new molecular targets with therapeutic potential is bound to increase, due to the efforts to understand the mechanisms of diseases and due to the data retrieved from genomics [1, 2],... 

---